Start
Completion

A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine

CompletedResults publishedRegisteredCTG

Randomised, placebo-controlled, triple-blind three-period crossover trial (n=40) in healthy men testing whether BI 409306, BI 425809 or lamotrigine reverse ketamine-induced cognitive deficits.

Details

Primary objective is to investigate whether BI 409306, BI 425809 and lamotrigine attenuate ketamine-induced cognitive deficits in healthy male participants.

Randomized, triple-masked, double-dummy three-treatment period crossover with matched placebo; participants receive each treatment in separate periods (total n=40, tablets/film-coated tablets). Cognitive assessments performed after ketamine challenge to measure memory and related outcomes.

Topics:Healthy Volunteers

Registry

Registry linkNCT04602221